Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: Implications for progression of Parkinsons disease
Individual response to Compounded GLP-1 medication varies, affecting the timing of appetite suppression
SN Comprehensive Clinical Medicine
Dr Reddys has said it plans to sell around 12 million semaglutide pens in the first year following launch, positioning itself as an early volume player once the patent barriers lift in March 2026
Transmission electron microscopy (TEM) (JEM1200EX, Japan) was used to observe the morphology of the preparations
received grants in support of investigator and investigator-initiated trials from Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Pfizer and Boehringer Ingelheim